Pharmacodynamic interaction
pharmacologyAn interaction in which two substances act on the same receptor, transmitter system, or physiological function, so their effects add to, oppose, or distort one another. It is distinguished from a pharmacokinetic interaction, where one substance changes how much of the other the body takes up, distributes, or clears — here the amount present is unchanged, and what that amount does is not.
Pharmacodynamic interactions describe what happens when two substances share biological territory — the same receptor, the same neurotransmitter system, or the same physiological control pathway — so the effect of one is shaped by the presence of the other.
The pharmacodynamic distinction matters because interactions have two fundamentally different sources. A pharmacokinetic interaction changes how much of a substance reaches its target; a pharmacodynamic interaction changes what that substance does once it arrives. Blood levels can be completely normal while the body's response is dramatically altered. Understanding which kind of interaction is at work changes how the risk should be read.
How it works · its role
Three patterns cover most pharmacodynamic interactions. Additive interactions occur when two substances engage the same mechanism and their effects simply sum — two CNS depressants at moderate individual doses can produce the same depth of sedation as a high dose of either alone.
Synergistic (or supra-additive) interactions go further: the combined effect exceeds the sum of each substance's individual contribution, amplifying beyond simple addition. Antagonistic interactions run in the opposite direction — one substance reduces or reverses the effect of another by competing for the same binding site or opposing the same physiological process.
Naloxone reversing an opioid overdose is a textbook pharmacodynamic antagonism: it binds opioid receptors with higher affinity than the opioid itself, displacing it and blocking its effects — without changing how much opioid is present in the blood.
Relevance to substances & effects
Pharmacodynamic interactions shape the risk profile of nearly every combined-substance scenario described across these pages.
CNS depressants — opioids, alcohol, benzodiazepines, and sedative-hypnotics — all suppress respiratory drive through overlapping mechanisms. Combining them additively or synergistically pushes that suppression well beyond what either substance would produce alone, which is why this combination pattern is implicated in so many overdose deaths.
Stimulants interact pharmacodynamically with other stimulants and with cardiovascular-active substances. Two drugs that each raise heart rate and blood pressure can push combined cardiovascular load into a dangerous range even when individual doses appear moderate.
Serotonergic substances — SSRIs, MAOIs, MDMA, serotonergic psychedelics — interact pharmacodynamically along shared pathways. The direction and consequences depend on which receptors and transporters are involved; the interaction layer on each substance page carries the specifics.
On each substance page, interactions are labelled as pharmacodynamic, pharmacokinetic, or both. That label is the first step in reading the risk correctly.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.